The use of Replicine™ Functional Keratin® to advance wound care in conditions ranging from Epidermolysis Bullosa to chronic wound care and acceleration of healing of complex wounds will be presented by clinicians at SAWC 2015, San Antonio, TX, USA, April 29-May 3.
Keraplast Technologies will be available for further discussion on the Replicine™ Functional Keratin®, the new paradigm in wound healing, at booth 252. Please join us at the forefront of wound care.
An evaluation of a keratin gel to accelerate healing and improve care for dystrophic epidermolysis bullosa patients, G Tadini, MD, U.O.S. Dermatologia Pediatrica – Dipartimento di Medicina Interna e Specializzazioni Mediche, IRCCS Ospedale Maggiore, Milano, Italy.
A clinical trial of a keratin gel to accelerate healing and improve comfort post haemorrhoidectomy, I Kolossa, MD, EBSQ, Intus Digestive and Colorectal Care, Christchurch, New Zealand.
Keratin dressings in the management of epidermolysis bullosa, J Denyer, Great Ormond Street Hospital, London, United Kingdom.
Effectiveness of topical therapies based on keratin for pressure sore in spinal cord injury, M Belci, MD, T Simone, MD, PRM, R Singhal, MD, L Stephen, RN, National Spinal Injury Centre, Stoke Mandeville, United Kingdom, University of Roma Tor Vergata, Italy and Burwood Hospital Spinal Unit, Christchurch, New Zealand.
Novel use of a keratin gel to epithelise areas with delayed healing as part of a procedure for giant nevus. J Jutkiewicz-Sypniewska, MD, M Plewko, MD, Department of Paediatric Surgery, Children’s Hospital of Professor J. Bogdanowicz, Warsaw, Poland